Voyer Philippe, Landreville Philippe, Moisan Jocelyne, Tousignant Michel, Préville Michel
Faculty of Nursing Sciences at Laval University, Quebec.
Int J Psychiatr Nurs Res. 2005 Jan;10(2):1093-116.
Benzodiazepine (BZD) drug use among seniors is an important public health issue because the benefit from their use is moderate and of short duration and numerous adverse events have been linked to their use. Furthermore, there is a significant discrepancy between the prevalence of mental health disorders and BZD drug use in the elderly population, which can be attributed to a measurement issue. The goal of this cross-sectional descriptive study was to determine the prevalence of mental health disorders among seniors using BZD and living in the community, basing this information on both a thorough face-to-face interview and a pair of self-reported validated instruments. Among the 216 seniors recruited in our study, nearly 20 % were users of BZD and over three quarters of them had been using this drug for more than a year. Thirteen subjects were recognized as depressed according to a self-report measure compared to 18 according to the interview. Likewise, 13 seniors were categorized as anxious, based on a self-report questionnaire compared to 39 based on the interview. Among self-reported measures of mental health variables, logistic regression indicated that insomnia increases by 7 the likelihood of using BZD (odds ratio: 7.2) and is the only statistically significant variable associated with BZD consumption. Based on thorough interviews, logistic regression showed that insomnia (odds ratio: 6.9) is still the dominant symptom associated with BZD drugs. In conclusion, our results clearly support the assertion that mental health status is influenced according to how it is measured. Finally, nurses should be aware that not all individuals are capable of expressing their mental health problems using either psychological or emotional terminologies. They may opt for expressing their psychological suffering as a physical symptom such as sleeping problems.
老年人使用苯二氮䓬类(BZD)药物是一个重要的公共卫生问题,因为其使用带来的益处有限且持续时间短,并且已发现使用这类药物会引发众多不良事件。此外,老年人群中心理健康障碍的患病率与BZD药物使用情况之间存在显著差异,这可能归因于测量问题。这项横断面描述性研究的目的是,通过全面的面对面访谈和一对经过验证的自我报告工具,确定在社区中使用BZD的老年人心理健康障碍的患病率。在我们研究招募的216名老年人中,近20%是BZD使用者,其中超过四分之三使用该药物已超过一年。根据自我报告测量,有13名受试者被认定为抑郁,而根据访谈则有18名。同样,根据自我报告问卷,有13名老年人被归类为焦虑,而根据访谈则有39名。在心理健康变量的自我报告测量中,逻辑回归表明失眠使使用BZD的可能性增加7倍(比值比:7.2),并且是与BZD消费相关的唯一具有统计学意义的变量。基于全面访谈,逻辑回归显示失眠(比值比:6.9)仍然是与BZD药物相关的主要症状。总之,我们的结果明确支持这样一种观点,即心理健康状况会因测量方式的不同而受到影响。最后,护士应该意识到,并非所有个体都能够用心理或情感术语来表达他们的心理健康问题。他们可能会选择将心理痛苦表达为身体症状,比如睡眠问题。